Double Stranded RNA Dependent Protein Kinase (PKR) and Type 2 Diabetes
Pharmacy & Pharmacology International Journal · 2015
DOI: 10.15406/ppij.2015.02.00015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy & Pharmacology International Journal, 2015. Verfasst von Arti Dhar. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes greatly increases the risk for developing cardiovascular and metabolic disorders.Despite recent development in medical science, scientific understandings on the root mechanisms of type 2 diabetes are still not fully understood, and such insufficient understanding contributes to the relative lack of effective treatments for such diseases.Protein Kinase R (PKR) is a serine threonine kinase activated during various stress conditions.Activation of PKR can increase reactive oxygen species generation, inflammation and induce oxidative stress.In this review we discuss the potential role of PKR in type 2 diabetes, pathways activated by it and the interrelationship between pathways activated.Specific and effective inhibitors of PKR are being developed and can become potential treatment for type 2 diabetes and prevent many diseases.
Zitieren
APA
Dhar, A. (2015). Double Stranded RNA Dependent Protein Kinase (PKR) and Type 2 Diabetes. Pharmacy & Pharmacology International Journal. https://doi.org/10.15406/ppij.2015.02.00015
Vancouver
Dhar A. Double Stranded RNA Dependent Protein Kinase (PKR) and Type 2 Diabetes. Pharmacy & Pharmacology International Journal. 2015. doi:10.15406/ppij.2015.02.00015
BibTeX
@article{Dhar2015,
author = {Dhar, Arti},
title = {Double Stranded RNA Dependent Protein Kinase (PKR) and Type 2 Diabetes},
journal = {Pharmacy & Pharmacology International Journal},
year = {2015},
doi = {10.15406/ppij.2015.02.00015}
}
EUVIMED